Technology

SafeLogic’s CryptoComply Encryption Software Achieves FIPS 140-3 Validation

Published

2 years ago

August 29, 2024

FIPS 140-3 is the latest FIPS 140 standard from NIST and represents the gold standard for cryptographic module validation

PALO ALTO, Calif., Aug. 29, 2024 /PRNewswire-PRWeb/ — SafeLogic is excited to announce that its CryptoComply v3 encryption software has achieved FIPS 140-3 validation from the National Institute of Standards (NIST). FIPS 140-3 is the latest FIPS 140 standard from NIST and represents the gold standard for cryptographic module validation. CryptoComply has been issued FIPS 140-3 certificate #4781.

Achieving this validation is a testament to CryptoComply’s adherence to the most rigorous cryptographic standards. SafeLogic customers now have options to migrate from FIPS 140-2 to FIPS 140-3 either now, in 2025, or into 2026, depending on their timing preferences.

Attaining FIPS 140-3 validation requires cryptographic module vendors to comply with strict FIPS 140-3 requirements for implementing cryptographic functionality. Once a cryptographic module is designed, implemented, tested, and documented, it must go through rigorous FIPS 140-3 testing by an accredited laboratory. That testing spans activities such as code review, secure SDLC review, algorithm testing, and operational testing.

When laboratory testing is completed, the submission goes to the Cryptographic Module Validation Program (CMVP), a joint effort between NIST and the Canadian Centre for Cyber Security, which conducts its own review. The complete process often takes years. Achieving FIPS 140-3 validation, receiving a FIPS 140-3 certificate, and getting listed in the CMVP database is the culmination of all that effort and an acknowledgment that the resulting cryptographic module meets the highest standards for cryptographic implementation.

SafeLogic’s new FIPS 140-3 validated CryptoComply software is the latest addition to the company’s existing library of various FIPS 140 validated CryptoComply modules. Among these modules are those that are compatible with the OpenSSL 3.x architecture and Java. For maximum interoperability, those modules are available across a wide array of platforms (e.g., server, mobile, mainframe, embedded), operating systems (e.g., Linux, Windows, Mac, Android, iOS), and CPU architectures. The modules also offer extensive programming language support (e.g., C / C++, Java, .NET, Rust, Python, Go, etc.) and are often drop-in replacements for popular open-source cryptographic software.

All in all, SafeLogic’s FIPS 140-3 modules support dozens of Operating Environments (OEs) on which they have been rigorously tested. In fact, SafeLogic’s FIPS 140-3 validated CryptoComply v3 cryptographic software is certified across more than two dozen OEs, from mobile operating systems (e.g., iOS, iPadOS, and Android), to Windows, macOS, Windows Server, and several Linux distributions (e.g., AlmaLinux, Debian, FreeBSD, Oracle Solaris, Red Hat Enterprise Linux, Rocky Linux, SUSE Linux, and Ubuntu).

“SafeLogic is delighted to add this new FIPS 140-3 validated cryptographic module to its CryptoComply product lineup. Achieving this validation is a testament to CryptoComply’s adherence to the most rigorous cryptographic standards,” said Evgeny Gervis, SafeLogic CEO. “SafeLogic customers now have options to migrate from FIPS 140-2 to FIPS 140-3 either now, in 2025, or into 2026, depending on their timing preferences. Whatever our customers decide, SafeLogic’s FIPS 140 Validation-as-a-Service offers a unique combination of software and managed services to help our customers adopt FIPS 140-3 validated software and achieve certification in a seamless manner.”

Earlier this year, SafeLogic made its FIPS 140-3 modules available to its customers as part of an Early Access Program (EAP) because some companies have long development/release cycles and wanted early access to the software for integration testing. For SafeLogic’s subscription customers, the transition to FIPS 140-3 is covered by SafeLogic’s MaintainCert service, which is a component of SafeLogic’s broader FIPS 140 Validation-as-a-Service offering.

With MaintainCert, SafeLogic customers will be able to upgrade to this new FIPS 140-3 validated module at a time of their choosing between now and March 2026. SafeLogic’s white glove software and certification support will ensure that all of that happens smoothly. “Transitioning to FIPS 140-3 is no small undertaking. SafeLogic is proud to offer our customers a full white-glove migration path,” added Gervis.

If you are interested in SafeLogic’s latest FIPS 140-3 validated CryptoComply v3 cryptographic software, please e-mail sales@safelogic.com or contact your SafeLogic representative, who will be happy to assist you.

About SafeLogic

Founded in 2012, SafeLogic is a premier provider of cryptographic solutions that enable enduring privacy and trust in the ever-changing digital world. SafeLogic’s CryptoComply FIPS 140 validated cryptographic software modules support a broad range of platforms, programming languages, and operating environments. With its FIPS Validation-as-a-Service offering, SafeLogic expedites the delivery of FIPS 140 certificates for its CryptoComply customers. It then keeps those certificates active over time via a unique white-glove managed service that provides both software support and certification maintenance. CryptoComply is also the basis for SafeLogic’s post-quantum cryptography (PQC) capabilities, which include PQC algorithms, discovery, cryptoagility, and hybrid deployments. For more information, go to www.safelogic.com.

Media Contact

Mike Donaldson, SafeLogic, 1 3035700315, mike@safelogic.com, www.safelogic.com

View original content:https://www.prweb.com/releases/safelogics-cryptocomply-encryption-software-achieves-fips-140-3-validation-302233580.html

SOURCE SafeLogic

Technology

MATSON ANNOUNCES ADDITION OF 3 MILLION SHARES TO EXISTING SHARE REPURCHASE PROGRAM AND QUARTERLY DIVIDEND OF $0.36 PER SHARE

Published

32 minutes ago

April 23, 2026

HONOLULU, April 23, 2026 /PRNewswire/ — The Board of Directors of Matson, Inc. (NYSE: MATX), a leading U.S. carrier in the Pacific, approved adding three million shares to its existing share repurchase program and extending the program to December 31, 2029. As of April 23, 2026, the existing share repurchase program had approximately 0.7 million shares remaining. The Board also declared a second quarter dividend of $0.36 per common share. The dividend will be paid on June 4, 2026 to all shareholders of record as of the close of business on May 7, 2026.

“We are pleased to announce an additional three million shares to our existing share repurchase program,” said Matt Cox, Matson’s Chairman and Chief Executive Officer. “Since we commenced our share repurchase program in August 2021, we have repurchased approximately 14.3 million shares, or approximately 33% of the then outstanding shares, for a total cost of $1.3 billion. Going forward, we will continue to be both disciplined and opportunistic in our capital allocation, and we remain committed to returning excess cash to shareholders to create additional shareholder value over the long-term.”

Shares will be repurchased in the open market from time to time at the Company’s discretion, based on ongoing assessments of the capital needs of the business, the market price of its common shares and general market conditions. The Company may enter into Rule 10b5-1 plans to facilitate purchases under the program. The repurchase program may be suspended or discontinued at any time.

About the Company

Founded in 1882, Matson (NYSE: MATX) is a leading provider of ocean transportation and logistics services. Matson provides a vital lifeline of ocean freight transportation services to the domestic non-contiguous economies of Hawaii, Alaska, and Guam, and to other island economies in Micronesia. Matson also operates premium, expedited services from China to Long Beach, California, which includes cargo from other Asia origins, provides services to Okinawa, Japan and various islands in the South Pacific, and operates an international export service from Alaska to Asia. The Company’s fleet of owned and chartered vessels includes containerships, combination container and roll-on/roll-off ships and barges. Matson Logistics, established in 1987, extends the geographic reach of Matson’s transportation network throughout North America and Asia. Its integrated logistics services include rail intermodal, highway brokerage, warehousing, freight consolidation, supply chain management, and freight forwarding to Alaska. Additional information about the Company is available at www.matson.com.

Forward Looking Statements

Statements in this news release that are not historical facts are “forward-looking statements,” within the meaning of the Private Securities Litigation Reform Act of 1995, that involve a number of risks and uncertainties that could cause actual results to differ materially from those contemplated by the relevant forward-looking statement, including but not limited to, statements about capital allocation plans, the timing, manner and volume of repurchases of common shares pursuant to the repurchase program, and use of excess cash. These forward-looking statements are not guarantees of future performance. This release should be read in conjunction with our Annual Report on Form 10-K and our other filings with the SEC through the date of this release, which identify important factors that could affect the forward-looking statements in this release. We do not undertake any obligation to update our forward-looking statements.

View original content to download multimedia:https://www.prnewswire.com/news-releases/matson-announces-addition-of-3-million-shares-to-existing-share-repurchase-program-and-quarterly-dividend-of-0-36-per-share-302752377.html

SOURCE Matson, Inc.

Technology

Accord Specialty Pharmacy Named Finalist in MMIT’s 11th Annual Retail Specialty Pharmacy Patient Choice Awards

Published

2 hours ago

April 23, 2026

ORLANDO, Fla., April 23, 2026 /PRNewswire/ — Accord Specialty Pharmacy, an independent specialty pharmacy serving patients across multiple states, has been named a finalist in the MMIT Patient Choice Awards, a recognition based on patient-reported satisfaction and experience.

Accord was selected as the only independent pharmacy among finalists in its category, alongside national pharmacy organizations such as Walgreens Specialty Pharmacy and Walmart Specialty Pharmacy. This distinction highlights the company’s commitment to delivering personalized, high-touch care for patients managing complex and chronic conditions.

The MMIT Patient Choice Awards recognize specialty pharmacies that demonstrate excellence in patient satisfaction, service quality, and overall care experience. Finalists are determined based on direct patient feedback, making the recognition a meaningful reflection of the trust patients place in their pharmacy providers.

“Being recognized alongside national organizations and as the only independent finalist validates our belief that personalized, patient-centered care drives better outcomes. We are building a model that combines clinical depth, national reach, and operational flexibility to better serve patients, providers, and partners.” said AJ Patel, Founder and Pharmacy Manager of Accord Specialty Pharmacy.

Accord Specialty Pharmacy supports patients across complex specialty categories, including oncology, rare disease, and infusion, through a clinically driven, high-touch care model designed to improve access, adherence, and outcomes. The company’s approach emphasizes personalized support, responsive care coordination, and strong clinical engagement to help patients navigate complex therapies more effectively. With a growing national footprint and multi-state licensure, Accord is positioned to support patients, providers, and partners across diverse markets.

For more information, visit MMIT Announces Finalists of the 11th Specialty Pharmacy Patient Choice Awards – MMITNetwork.

About Accord Specialty Pharmacy:

Accord Specialty Pharmacy is an ACHC-accredited, multi-state licensed independent specialty pharmacy located in Central Florida, dedicated to delivering high-quality, patient-centered care for individuals managing complex and chronic conditions. Through personalized support, clinical expertise, and a high-touch approach, Accord helps patients navigate every step of their treatment journey. Learn more at www.accordspecialty.com.

CONTACT: contact@accordspecialty.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/accord-specialty-pharmacy-named-finalist-in-mmits-11th-annual-retail-specialty-pharmacy-patient-choice-awards-302752327.html

SOURCE Accord Specialty

Technology

HAIVISION ANNOUNCES VOTING RESULTS FROM 2026 ANNUAL MEETING OF SHAREHOLDERS

Published

2 hours ago

April 23, 2026

MONTRÉAL, April 23, 2026 /CNW/ – Haivision Systems Inc. (“Haivision” or the “Company”) (TSX: HAI) is pleased to announce the voting results from its annual meeting of shareholders held today in a virtual format.

A total of approximately 45.97 % of the issued and outstanding common shares of Haivision were represented at the meeting.

Election of Directors

Each of the six nominated directors of Haivision was elected as director of the Company with the following results:

Director

Votes
For

% Votes
For

Votes
Against

% Votes
Against

Miroslav Wicha

11,110,245

99.26 %

82,583

0.74 %

Harvey Bienenstock

11,155,137

99.66 %

37,691

0.34 %

Robin M. Rush

11,121,855

99.37 %

70,973

0.63 %

Neil Hindle

10,794,005

96.44 %

398,823

3.56 %

Julie Tremblay

10,941,969

97.76 %

250,859

2.24 %

Lee K. Levy II

9,084,418

81.16 %

2,108,410

18.84 %

2. Appointment of Auditors

Deloitte LLP were reappointed auditors of the Company for the ensuing year with 12,492,582 (98.84%) votes cast in favour and 146,406 (1.16%) votes withheld.

3. Approval of the Unallocated Awards under the Company’s Equity Incentive Plan

The Company’s unallocated awards were approved with 8,710,347 (77.82%) votes cast in favour and 2,482,481 (22.18%) votes cast against.

4. Reapproval of Company’s Shareholder Rights Plan

The Company’s shareholder rights plan was approved with 10,572,490 (94.46%) votes cast in favour and 620,338 (5.54%) votes cast against.

Final voting results on all matters voted on at the meeting will be filed under Haivision’s profile on SEDAR+ at www.sedarplus.ca.

About Haivision

Haivision is a leading global provider of mission-critical, real-time video streaming and visual collaboration solutions. Our connected cloud and intelligent edge technologies enable organizations globally to engage audiences, enhance collaboration, and support decision making. We provide high quality, low latency, secure, and reliable live video at a global scale. Haivision open sourced its award-winning SRT low latency video streaming protocol and founded the SRT Alliance to support its adoption. Awarded four Emmys® for Technology and Engineering from the National Academy of Television Arts and Sciences, Haivision continues to fuel the future of IP video transformation. Founded in 2004, Haivision is headquartered in Montreal and Chicago with offices, sales, and support located throughout the Americas, Europe, and Asia. Learn more at haivision.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/haivision-announces-voting-results-from-2026-annual-meeting-of-shareholders-302752318.html

SOURCE Haivision Systems Inc.